Reporting Manager
Nantahala Capital Management, LLC
Symbol
XTNT
Shares outstanding
139,295,316 shares
Disclosed Ownership
68,394,000 shares
Ownership
49%
Form type
SCHEDULE 13D/A
Filing time
05 Aug 2025, 16:30:32 UTC
Date of event
01 Aug 2025
Previous filing
17 Apr 2025

Quoteable Key Fact

"Nantahala Capital Management, LLC disclosed 49% ownership in Xtant Medical Holdings, Inc. Common Stock, par value $0.000001 per share (XTNT) on 01 Aug 2025."

Quick Takeaways

  • Nantahala Capital Management, LLC filed SCHEDULE 13D/A for Xtant Medical Holdings, Inc. Common Stock, par value $0.000001 per share (XTNT).
  • Disclosed ownership: 49%.
  • Date of event: 01 Aug 2025.

What Changed

  • Previous schedule filing date: 17 Apr 2025.
  • Current filing was accepted on 05 Aug 2025, 16:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Partners Limited Partnership 12% 16,380,396 0 16,380,396 /s/ Taki Vasilakis Taki Vasilakis, Chief Compliance Officer 0001502725
Nantahala Capital Management, LLC 49% 68,394,000 0 68,394,000 /s/ Taki Vasilakis Taki Vasilakis, Chief Compliance Officer 0001472322
Harkey Wilmot B. 49% 68,394,000 0 68,394,000 /s/ Wilmot B. Harkey Wilmot B. Harkey 0001775952
Mack Daniel 49% 68,394,000 0 68,394,000 /s/ Daniel Mack Daniel Mack 0001775831
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .